| Product NDC: | 43857-0111 | 
| Proprietary Name: | Coxsackie | 
| Non Proprietary Name: | Coxsackie B1, B4 | 
| Active Ingredient(s): | 200; 200 [hp_C]/mL; [hp_C]/mL & nbsp; Coxsackie B1, B4 | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | LIQUID | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 43857-0111 | 
| Labeler Name: | BioActive Nutritional, Inc. | 
| Product Type: | HUMAN OTC DRUG | 
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC | 
| Start Marketing Date: | 20121009 | 
| Package NDC: | 43857-0111-1 | 
| Package Description: | 30 mL in 1 BOTTLE, DROPPER (43857-0111-1) | 
| NDC Code | 43857-0111-1 | 
| Proprietary Name | Coxsackie | 
| Package Description | 30 mL in 1 BOTTLE, DROPPER (43857-0111-1) | 
| Product NDC | 43857-0111 | 
| Product Type Name | HUMAN OTC DRUG | 
| Non Proprietary Name | Coxsackie B1, B4 | 
| Dosage Form Name | LIQUID | 
| Route Name | ORAL | 
| Start Marketing Date | 20121009 | 
| Marketing Category Name | UNAPPROVED HOMEOPATHIC | 
| Labeler Name | BioActive Nutritional, Inc. | 
| Substance Name | HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B4 | 
| Strength Number | 200; 200 | 
| Strength Unit | [hp_C]/mL; [hp_C]/mL | 
| Pharmaceutical Classes |